• Global Research on Coronavirus Disease (COVID-19)

WHO is gathering the latest international multilingual scientific findings and knowledge on COVID-19. This database represents a comprehensive multilingual source of current literature on the topic. While it may not be exhaustive, new research is added regularly. For further details kindly click the link below;

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov

  • Remdesivir Clinical Trials

Gilead has initiated two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with COVID-19 following the U.S. Food and Drug Administration’s (FDA) rapid review and acceptance of Gilead’s investigational new drug (IND) filing. These randomized, open-label, multicenter studies began enrolling patients in March 2020 and will enroll a total of approximately 1,000 patients in the initial phase of the studies, in countries with high prevalence of COVID-19. For further details kindly click the links below;

https://www.gilead.com/purpose/advancing-global-health/covid-19/remdesivir-clinical-trials

https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins

  • COVID-19 Breakthrough as Cambridge Company Identifies Top Ranked Drugs for Treatment

A revolutionary systems pharmacology platform powered by artificial intelligence has identified the top candidate drugs that are highly likely to be effective in treating COVID-19 disease. Five of the top-ranked drugs on the list, that have already entered clinical trials for COVID-19, include:

  1. Chloroquine, the anti-malarial drug
  2. Dexamethasone, a commonly used corticosteroid
  3. Sirolimus, an immuno-suppressant drug
  4. Tacrolimus, an immuno-suppressant drug
  5. Thalidomide, a cancer treatment drug

For further details kindly click the links below;

https://www.cambridgenetwork.co.uk/news/covid-19-breakthrough-cambridge-company-identifies-top-ranked-drugs-treatment

  • The Proceedings of the National Academies of Sciences (PNAS) just secured a major breakthrough in COVID-19 therapeutics.

In preliminary findings published in the journal PNAS, a single 200 mL dose of convalescent plasma (CP) from COVID-19 patients who recently recovered shortened the duration of symptoms, improved oxygen levels and expedited viral clearance in patients who were still suffering from the disease.

For further details kindly click the links below;

https://www.theladders.com/career-advice/this-research-may-be-a-covid-19-treatment-breakthrough

  • Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.

The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.

For further details kindly click the links below;

https://www.ncbi.nlm.nih.gov/pubmed/32074550


Disclaimer of Liability: The material and information contained on this website is for general information purpose only. You should not rely upon the material or information on the website as a basis for making any business, legal or any other decision. COMSTECH is not endorsing these products or materials.

COMSTECH News & Announcements
  • 05June
    2020

  • 06May
    2020

    Click here to watch the recording of the Seminar.


  • April
    2020

    Coordinator General, COMSTECH Meets Minister of Science and Technology


  • 30April
    2020

    Prime Minister Visits MoST Exhibition on COVID-19-Related Products at COMSTECH


  • April
    2020

    The President of Pakistan in his capacity as Chairman COMSTECH has appointed, Prof. Dr. M. Iqbal Choudhary as the Coordinator General of COMSTECH.


  • 20Feb
    2020
    Mr. Samir Guliyev, 2nd Secretary (Deputy Head of Mission), Embassy of the Republic of Azerbaijan
  • 3 - 4Mar
    2020
    STIO 2026
  • 28-29Jan
    2020
    Sustainable-Cities
  • 14-15Jan
    2020
    OMSTECH-Inter-Islamic-network
  • 18-19Mar
    2019
    Steering-Committee
  • 27Nov
    2019
    science-diplomacy-2019
  • 19Nov
    2019
    CG
  • 18-19Nov
    2019

    Plants Genetics


  • Nov
    2019
    Robotics
  • Nov
    2019
    OIC Robotics Winner
  • 16Oct
    2019
    Brain-Machine Interface

    A Public Lecture by Dr. Naweed. I. Syed “Brain – Machine Interface: Future of Artificial Intelligence, Machine Learning and Singularity”


  • 27-31Oct
    2019
    OIC Robotics
  • 21Sep
    2019
    adviser

    COMSTECH delegate visits Malaysian institutions to accelerate implementation of OIC STI Agenda 2026


  • 20Sep
    2019
    FAO-COMSTECH

    Dr. Bo Zhou, the Senior Agricultural Officer at (FAO) had a meeting at COMSTECH head office Islamabad with Dr. Khurshid Hasanain (Adviser COMSTECH)


  • 04Sep
    2019
    comstech awards 2019
  • 18July
    2019

    QAU and COMSTECH organize International Symposium on Biodiversity and Big Health Data and 2nd Annual Meeting of Biodiversity and Health Big Data (BHBD) Alliance


  • May
    2019

    COMSTECH Awards


  • 29-31July,
    2019



Previous News & Announcements >>

Announcements from OIC Institutions
External News & Announcements
COMSTECH Secretariat, 33-Constitution Avenue, G-5/2, Islamabad Phone: (+92 51) 9220681 - Fax: (+92 51) 9211115 - COMSTECH Primary Email    |    COMSTECH Secondary Email